Skip to content
Inciteful Med

Getting an Accurate Diagnosis

Last updated:

Autosomal Dominant Optic Atrophy (ADOA) is primarily diagnosed using Optical Coherence Tomography (OCT) scans to detect specific retinal thinning, alongside genetic testing for the OPA1 gene. Specialized tests help differentiate ADOA from similar conditions like glaucoma and LHON.

Key Takeaways

  • • OCT scans help diagnose ADOA by revealing specific thinning in the Ganglion Cell Complex and Retinal Nerve Fiber Layer.
  • • ADOA is frequently misdiagnosed as Normal Tension Glaucoma, but specialized eye exams and pupil response tests can tell them apart.
  • • Unlike LHON, which causes sudden vision loss, ADOA typically causes slow, progressive vision changes that begin in childhood.
  • • Genetic testing, most commonly for the OPA1 gene, is the gold standard for confirming an ADOA diagnosis.
  • • Patients are strongly encouraged to work with a genetic counselor to understand inheritance risks and family planning options.

Because the symptoms of Autosomal Dominant Optic Atrophy (ADOA) can overlap with other eye conditions, getting a definitive diagnosis requires a combination of high-tech imaging and genetic detective work. Understanding these tests can empower you to ask the right questions and ensure your diagnosis is accurate.

The Role of OCT: Mapping the Damage

The most important tool for visualizing the effects of ADOA is Optical Coherence Tomography (OCT). This is a non-invasive test that takes cross-sectional “photos” of the layers of your retina [1].

In a person with ADOA, the OCT typically shows two specific types of thinning:

  • Ganglion Cell Complex (GCC) Thinning: ADOA causes the loss of the ganglion cells in the center of the retina. A key diagnostic marker is thinning in the nasal inner macula (the part of the central retina closest to the nose) [2][3].
  • Retinal Nerve Fiber Layer (RNFL) Thinning: The optic nerve fibers themselves become thinner. In early ADOA, this thinning is often most visible in the temporal sector (the side of the nerve closest to the ear), which corresponds to the fibers responsible for your central vision [3][4].

Differentiating ADOA from Glaucoma

ADOA is frequently misdiagnosed as Normal Tension Glaucoma (NTG) because both involve a pale optic nerve and vision loss without high eye pressure [5]. However, doctors can use OCT to tell them apart:

  • Lamina Cribrosa (LC) Depth: The LC is the “floor” of the optic nerve. In glaucoma, this floor is often deep and curved backward. In ADOA, the LC depth usually looks the same as it does in a healthy eye [6][7].
  • Pupil Response: A specialized test called chromatic pupillometry can be a “smoking gun.” In ADOA, the cells that control how your pupils react to blue light (ipRGCs) are often protected and function normally. In glaucoma, these specific cells are usually damaged [8][9].

Differentiating ADOA from LHON

While both are mitochondrial conditions, ADOA and Leber’s Hereditary Optic Neuropathy (LHON) have different “signatures”:

  • Speed of Onset: LHON usually causes a sudden, severe drop in vision over weeks or months, typically in young adults [10][11]. ADOA is much slower and usually begins in childhood [12][13].
  • Genetic Source: LHON is found in the mitochondrial DNA (inherited only from the mother), while ADOA is found in the nuclear DNA (inherited from either parent) [10][14].

The Final Confirmation: Genetic Testing

Genetic testing is the gold standard for confirming ADOA. Because genetic results affect not just you but your entire family—including the 50% chance of passing the gene to each child—it is strongly recommended that you undergo testing alongside a certified Genetic Counselor. They can help you interpret the results and discuss family planning implications.

  • The OPA1 Gene: Mutations in OPA1 are responsible for the vast majority of cases [15].
  • Beyond OPA1: If an OPA1 test is negative, doctors may look for rarer genes like AFG3L2, SSBP1, or OPA3 [16][17].
  • Copy Number Variations (CNVs): Sometimes, a standard test misses a large “chunk” of missing or extra DNA. If your results are unclear, your doctor may order a specific test to look for these CNVs [17][18].

Frequently Asked Questions

How does an OCT scan help diagnose ADOA?
An OCT scan is a non-invasive imaging test that takes cross-sectional pictures of your retina. In ADOA, it typically shows characteristic thinning in both the Ganglion Cell Complex and the Retinal Nerve Fiber Layer.
How can doctors tell the difference between ADOA and Normal Tension Glaucoma?
Doctors examine the lamina cribrosa, or the floor of the optic nerve, which looks normal in ADOA but is typically deep and curved in glaucoma. They may also use chromatic pupillometry to test your pupil's response to blue light, which remains normal in ADOA.
What is the difference between ADOA and LHON?
While both are genetic conditions affecting the optic nerve, ADOA usually causes slow, gradual vision loss starting in childhood. LHON typically causes sudden, severe vision loss in young adults and is inherited only from the mother, whereas ADOA can be inherited from either parent.
What gene causes Autosomal Dominant Optic Atrophy?
Mutations in the OPA1 gene cause the vast majority of ADOA cases. If standard testing is negative, doctors may look for rarer gene mutations like AFG3L2, SSBP1, or OPA3, or check for missing chunks of DNA called copy number variations.
Should I see a genetic counselor if I suspect I have ADOA?
Yes, meeting with a certified genetic counselor is highly recommended. They can help you interpret your genetic test results, understand family planning implications, and discuss the 50% chance of passing the gene to each child.

Questions for Your Doctor

  • • Does my OCT show thinning in the nasal inner macula, which is a common marker for ADOA?
  • • How does the depth of my lamina cribrosa (the 'floor' of the optic nerve) help rule out Normal Tension Glaucoma?
  • • If my initial OPA1 screening was negative, should we test for 'Copy Number Variations' or other genes like AFG3L2 and SSBP1?
  • • Can you perform a 'chromatic pupillometry' test to see if my blue-light pupillary response is protected, pointing toward ADOA rather than glaucoma?
  • • Can you refer me to a genetic counselor to help my family and I understand the inheritance risks?

Questions for You

  • • At what age did I first notice my vision changing, and was it a sudden or very gradual shift?
  • • Have I ever been diagnosed with or treated for 'Normal Tension Glaucoma' in the past?
  • • Do I have any relatives with a history of early-onset hearing loss or balance issues that I should tell my doctor about?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Detecting Progression in Patients With Different Clinical Presentations of Primary Open-angle Glaucoma.

    Abu SL, Marín-Franch I, Racette L

    Journal of glaucoma 2021; (30(9)):769-775 doi:10.1097/IJG.0000000000001843.

    PMID: 33867504
  2. 2

    Clinical and Structural Parameters in Autosomal Dominant Optic Atrophy Patients: A Cross-Sectional Study Using Optical Coherence Tomography.

    Camós-Carreras A, Figueras-Roca M, Albà-Arbalat S, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2024; (45(3)):273-277 doi:10.1097/WNO.0000000000002294.

    PMID: 39805076
  3. 3

    Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy.

    Corajevic N, Larsen M, Rönnbäck C

    Acta ophthalmologica 2018; (96(3)):251-256 doi:10.1111/aos.13588.

    PMID: 29091347
  4. 4

    The reduction of temporal optic nerve head microcirculation in autosomal dominant optic atrophy.

    Inoue M, Himori N, Kunikata H, et al.

    Acta ophthalmologica 2016; (94(7)):e580-e585 doi:10.1111/aos.12999.

    PMID: 26936288
  5. 5

    [Differential diagnosis of juvenile normal pressure glaucoma].

    Geidel K, Wiedemann P, Unterlauft JD

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2017; (114(9)):828-831 doi:10.1007/s00347-016-0407-5.

    PMID: 27921132
  6. 6

    Comparison of Lamina Cribrosa Morphology in Normal Tension Glaucoma and Autosomal-Dominant Optic Atrophy.

    Kim GN, Kim JA, Kim MJ, et al.

    Investigative ophthalmology & visual science 2020; (61(5)):9 doi:10.1167/iovs.61.5.9.

    PMID: 32392317
  7. 7

    Lamina cribrosa position and Bruch's membrane opening differences between anterior ischemic optic neuropathy and open-angle glaucoma.

    Rebolleda G, Pérez-Sarriegui A, Díez-Álvarez L, et al.

    European journal of ophthalmology 2019; (29(2)):202-209 doi:10.1177/1120672118782101.

    PMID: 29911429
  8. 8

    Pupillometric evaluation of the melanopsin containing retinal ganglion cells in mitochondrial and non-mitochondrial optic neuropathies.

    Ba-Ali S, Lund-Andersen H

    Mitochondrion 2017; (36()):124-129 doi:10.1016/j.mito.2017.07.003.

    PMID: 28716667
  9. 9

    Chromatic pupil campimetry as objective diagnostic tool for progressive optic neuropathies.

    Edelmayer MV, Strasser T, Jung R, et al.

    Documenta ophthalmologica. Advances in ophthalmology 2025; doi:10.1007/s10633-025-10054-x.

    PMID: 41094347
  10. 10

    Mitochondrial optic neuropathies.

    Carelli V, La Morgia C, Yu-Wai-Man P

    Handbook of clinical neurology 2023; (194()):23-42 doi:10.1016/B978-0-12-821751-1.00010-5.

    PMID: 36813316
  11. 11

    [Hereditary Optic Neuropathies].

    Rüther K

    Klinische Monatsblatter fur Augenheilkunde 2018; (235(6)):747-763 doi:10.1055/a-0583-6290.

    PMID: 29490390
  12. 12

    Autosomal dominant optic atrophy caused by six novel pathogenic OPA1 variants and genotype-phenotype correlation analysis.

    Han J, Li Y, You Y, et al.

    BMC ophthalmology 2022; (22(1)):322 doi:10.1186/s12886-022-02546-0.

    PMID: 35883160
  13. 13

    The crossroads of Leber hereditary optic neuropathy and autosomal dominant optic Atrophy: Clinical profiles of patients with coexisting pathogenic genetic variants.

    Halawani MA, Badeeb NO

    American journal of ophthalmology case reports 2025; (38()):102346 doi:10.1016/j.ajoc.2025.102346.

    PMID: 40417638
  14. 14

    Family Planning in Genetic Optic Atrophies in Israel, a Case Series and a Discussion of Ethical Considerations.

    Rozanes E, Ben-Arzi A, Boas H, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2025; (45(2)):153-157 doi:10.1097/WNO.0000000000002232.

    PMID: 39080811
  15. 15

    Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy.

    Ahuja AS, Selvam P, Vadlamudi C, et al.

    Ophthalmic genetics 2020; (41(6)):563-569 doi:10.1080/13816810.2020.1814344.

    PMID: 32940104
  16. 16

    The importance of genome sequencing: unraveling SSBP1 variant missed by exome sequencing.

    Jun JW, Seo Y, Han SH, Han J

    Ophthalmic genetics 2023; (44(3)):286-290 doi:10.1080/13816810.2022.2109685.

    PMID: 35946466
  17. 17

    Identification of copy number variation in the gene for autosomal dominant optic atrophy, OPA1, in a Chinese pedigree.

    Jin X, Chen YH, Liu Z, et al.

    Genetics and molecular research : GMR 2015; (14(3)):10961-72 doi:10.4238/2015.September.21.8.

    PMID: 26400325
  18. 18

    The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy.

    Zhang AM, Bi R, Hu QX, et al.

    Molecular neurobiology 2017; (54(3)):1622-1630 doi:10.1007/s12035-016-9771-z.

    PMID: 26867657

This page explains diagnostic testing for Autosomal Dominant Optic Atrophy for educational purposes. Always consult an ophthalmologist or neuro-ophthalmologist for an accurate diagnosis and interpretation of your eye scans and genetic tests.

Stay up to date

Get notified when new research about Autosomal dominant optic atrophy is published.

No spam. Unsubscribe anytime.